MNPR
Monopar Therapeutics
NASDAQ · Healthcare · Biotechnology · US
$72.81
+4.18%0
Insider buys (3m)
26
Insider sells (3m)
-$4.8M
Net value (3m)
-40.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 20, 2026 | Robinson Chandler · director, officer: Chief Executive Officer | F-InKind | 597 | $93 |
| Oct 5, 2026 | STARR CHRISTOPHER M · director | Sale | 4,631 | $78 |
| Oct 5, 2026 | STARR CHRISTOPHER M · director | M-Exempt | 8,400 | $0.01 |
| Oct 5, 2026 | STARR CHRISTOPHER M · director | Sale | 799 | $80 |
| Oct 5, 2026 | STARR CHRISTOPHER M · director | Sale | 2,970 | $79 |
| Oct 2, 2026 | Cittadine Andrew · officer: Chief Operating Officer | M-Exempt | 4,384 | $0.00 |
| Oct 2, 2026 | Robinson Chandler · director, officer: Chief Executive Officer | M-Exempt | 9,801 | $0.00 |
| Oct 2, 2026 | Vu Quan Anh · officer: Chief Financial Officer | F-InKind | 180 | $80 |
| Oct 2, 2026 | Vu Quan Anh · officer: Chief Financial Officer | M-Exempt | 614 | $0.00 |
| Oct 2, 2026 | Robinson Chandler · director, officer: Chief Executive Officer | F-InKind | 4,344 | $80 |
| Oct 2, 2026 | Cittadine Andrew · officer: Chief Operating Officer | F-InKind | 1,944 | $80 |
| Sep 28, 2026 | Robinson Chandler · director, officer: Chief Executive Officer | Sale | 600 | $90 |
| Sep 28, 2026 | Robinson Chandler · director, officer: Chief Executive Officer | Sale | 8,368 | $89 |
| Sep 28, 2026 | Robinson Chandler · director, officer: Chief Executive Officer | Sale | 9,638 | $88 |
| Sep 28, 2026 | Robinson Chandler · director, officer: Chief Executive Officer | Sale | 10,450 | $87 |
| Sep 28, 2026 | Robinson Chandler · director, officer: Chief Executive Officer | M-Exempt | 15,000 | $14 |
| Sep 28, 2026 | Robinson Chandler · director, officer: Chief Executive Officer | M-Exempt | 14,056 | $30 |
| Aug 28, 2026 | Tsuchimoto Kim R · director | Sale | 590 | $114 |
| Aug 28, 2026 | Tsuchimoto Kim R · director | M-Exempt | 2,055 | $30 |
| Aug 28, 2026 | Tsuchimoto Kim R · director | M-Exempt | 2,035 | $14 |
| Aug 28, 2026 | Tsuchimoto Kim R · director | Sale | 485 | $109 |
| Aug 28, 2026 | Tsuchimoto Kim R · director | Sale | 615 | $110 |
| Aug 28, 2026 | Tsuchimoto Kim R · director | Sale | 700 | $111 |
| Aug 28, 2026 | Tsuchimoto Kim R · director | Sale | 1,098 | $112 |
| Aug 28, 2026 | Tsuchimoto Kim R · director | Sale | 602 | $113 |
| Aug 28, 2026 | Anderson Raymond · director | M-Exempt | 1,402 | $30 |
| Aug 28, 2026 | Anderson Raymond · director | M-Exempt | 1,740 | $30 |
| Aug 28, 2026 | Anderson Raymond · director | Sale | 694 | $110 |
| Aug 28, 2026 | Anderson Raymond · director | Sale | 646 | $111 |
| Aug 28, 2026 | Anderson Raymond · director | Sale | 1,802 | $113 |
Institutional positioning
13F filings over the trailing two quarters
New 56Increased 64Reduced 44Sold out 14
| Filer | Action | Shares | Filed |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | Unchanged | 1,317,410 | May 18, 2026 |
| Jupiter Topco LLC | New Position | 1,312,129 | Aug 14, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Unchanged | 667,207 | Aug 14, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Unchanged | 667,207 | May 15, 2026 |
| BlackRock, Inc. | Increased | 348,819 | Aug 7, 2026 |
| SATURN V CAPITAL MANAGEMENT LLC | Increased | 345,626 | May 15, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | Unchanged | 323,745 | Aug 14, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Increased | 323,745 | May 15, 2026 |
| BLACKROCK, INC. | Increased | 316,567 | May 13, 2026 |
| Saturn V Capital Management LP | Reduced | 311,976 | Aug 14, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Reduced | 309,195 | May 15, 2026 |
| Siren, L.L.C. | Unchanged | 270,118 | Aug 13, 2026 |
| SIREN, L.L.C. | Increased | 270,118 | May 14, 2026 |
| ADAR1 CAPITAL MANAGEMENT, LLC | Reduced | 264,278 | May 18, 2026 |
| POLAR CAPITAL HOLDINGS PLC | Increased | 226,526 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 20, 2026